These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 31629573

  • 1. Effect of Vitamin B12 Levels on the Association Between Folic Acid Treatment and CKD Progression: A Post Hoc Analysis of a Folic Acid Interventional Trial.
    Li Y, Spence JD, Wang X, Huo Y, Xu X, Qin X.
    Am J Kidney Dis; 2020 Mar; 75(3):325-332. PubMed ID: 31629573
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease: The Renal Substudy of the China Stroke Primary Prevention Trial.
    Xu X, Qin X, Li Y, Sun D, Wang J, Liang M, Wang B, Huo Y, Hou FF, investigators of the Renal Substudy of the China Stroke Primary Prevention Trial (CSPPT).
    JAMA Intern Med; 2016 Oct 01; 176(10):1443-1450. PubMed ID: 27548766
    [Abstract] [Full Text] [Related]

  • 3. Effects of Folic Acid Therapy on the New-Onset Proteinuria in Chinese Hypertensive Patients: A Post Hoc Analysis of the Renal Substudy of CSPPT (China Stroke Primary Prevention Trial).
    Li Y, Liang M, Wang G, Wang B, He M, Tang G, Yin D, Xu X, Huo Y, Cui Y, Hou FF, Qin X.
    Hypertension; 2017 Aug 01; 70(2):300-306. PubMed ID: 28607125
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial.
    Huo Y, Li J, Qin X, Huang Y, Wang X, Gottesman RF, Tang G, Wang B, Chen D, He M, Fu J, Cai Y, Shi X, Zhang Y, Cui Y, Sun N, Li X, Cheng X, Wang J, Yang X, Yang T, Xiao C, Zhao G, Dong Q, Zhu D, Wang X, Ge J, Zhao L, Hu D, Liu L, Hou FF, CSPPT Investigators.
    JAMA; 2015 Apr 07; 313(13):1325-35. PubMed ID: 25771069
    [Abstract] [Full Text] [Related]

  • 5. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.
    McCallum W, Tighiouart H, Ku E, Salem D, Sarnak MJ.
    Am J Kidney Dis; 2020 Jan 07; 75(1):21-29. PubMed ID: 31303349
    [Abstract] [Full Text] [Related]

  • 6. MTHFR Gene and Serum Folate Interaction on Serum Homocysteine Lowering: Prospect for Precision Folic Acid Treatment.
    Huang X, Qin X, Yang W, Liu L, Jiang C, Zhang X, Jiang S, Bao H, Su H, Li P, He M, Song Y, Zhao M, Yin D, Wang Y, Zhang Y, Li J, Yang R, Wu Y, Hong K, Wu Q, Chen Y, Sun N, Li X, Tang G, Wang B, Cai Y, Hou FF, Huo Y, Wang H, Wang X, Cheng X.
    Arterioscler Thromb Vasc Biol; 2018 Mar 07; 38(3):679-685. PubMed ID: 29371246
    [Abstract] [Full Text] [Related]

  • 7. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
    Jamison RL, Hartigan P, Kaufman JS, Goldfarb DS, Warren SR, Guarino PD, Gaziano JM, Veterans Affairs Site Investigators.
    JAMA; 2007 Sep 12; 298(10):1163-70. PubMed ID: 17848650
    [Abstract] [Full Text] [Related]

  • 8. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM, Nguyen H, Gonin R, Sarna A, Michels A, Masri-Imad F, Bommareddy G, Chassaing C, Wainer I, Loya A, Cary D, Barker LF, Assefi A, Greenspan R, Mahoney D, Wilcox CS.
    J Nephrol; 2003 Sep 12; 16(4):522-34. PubMed ID: 14696754
    [Abstract] [Full Text] [Related]

  • 9. Folic acid with or without vitamin B12 for cognition and dementia.
    Malouf M, Grimley EJ, Areosa SA.
    Cochrane Database Syst Rev; 2003 Sep 12; (4):CD004514. PubMed ID: 14584018
    [Abstract] [Full Text] [Related]

  • 10. Interaction of Serum Alkaline Phosphatase and Folic Acid Treatment on Chronic Kidney Disease Progression in Treated Hypertensive Adults.
    Zhang Y, He P, Wang G, Liang M, Xie D, Nie J, Liu C, Song Y, Liu L, Wang B, Li J, Zhang Y, Wang X, Huo Y, Hou FF, Xu X, Qin X.
    Front Pharmacol; 2021 Sep 12; 12():753803. PubMed ID: 35095485
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial.
    Sircar D, Chatterjee S, Waikhom R, Golay V, Raychaudhury A, Chatterjee S, Pandey R.
    Am J Kidney Dis; 2015 Dec 12; 66(6):945-50. PubMed ID: 26233732
    [Abstract] [Full Text] [Related]

  • 12. [Should patients with chronic renal insufficiency be treated with folic acid, vitamin B6 and vitamin B12?].
    Birn H.
    Ugeskr Laeger; 2008 Mar 10; 170(11):933-7. PubMed ID: 18397619
    [Abstract] [Full Text] [Related]

  • 13. Folic Acid Therapy Reduces the First Stroke Risk Associated With Hypercholesterolemia Among Hypertensive Patients.
    Qin X, Li J, Spence JD, Zhang Y, Li Y, Wang X, Wang B, Sun N, Chen F, Guo J, Yin D, Sun L, Tang G, He M, Fu J, Cai Y, Shi X, Ye P, Chen H, Zhao S, Chen M, Gao C, Kong X, Hou FF, Huang Y, Huo Y.
    Stroke; 2016 Nov 10; 47(11):2805-2812. PubMed ID: 27729579
    [Abstract] [Full Text] [Related]

  • 14. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Yang W, Xie D, Anderson AH, Joffe MM, Greene T, Teal V, Hsu CY, Fink JC, He J, Lash JP, Ojo A, Rahman M, Nessel L, Kusek JW, Feldman HI, CRIC Study Investigators.
    Am J Kidney Dis; 2014 Feb 10; 63(2):236-43. PubMed ID: 24182662
    [Abstract] [Full Text] [Related]

  • 15. Hyperhomocysteinemia predicts renal function decline: a prospective study in hypertensive adults.
    Xie D, Yuan Y, Guo J, Yang S, Xu X, Wang Q, Li Y, Qin X, Tang G, Huo Y, Deng G, Wu S, Wang B, Zhang Q, Wang X, Fang P, Wang H, Xu X, Hou F.
    Sci Rep; 2015 Nov 10; 5():16268. PubMed ID: 26553372
    [Abstract] [Full Text] [Related]

  • 16. Folic acid therapy reduces serum uric acid in hypertensive patients: a substudy of the China Stroke Primary Prevention Trial (CSPPT).
    Qin X, Li Y, He M, Tang G, Yin D, Liang M, Wang B, Nie J, Huo Y, Xu X, Hou FF.
    Am J Clin Nutr; 2017 Apr 10; 105(4):882-889. PubMed ID: 28148501
    [Abstract] [Full Text] [Related]

  • 17. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people.
    Malouf R, Grimley Evans J.
    Cochrane Database Syst Rev; 2008 Oct 08; (4):CD004514. PubMed ID: 18843658
    [Abstract] [Full Text] [Related]

  • 18. Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial.
    Kimura K, Hosoya T, Uchida S, Inaba M, Makino H, Maruyama S, Ito S, Yamamoto T, Tomino Y, Ohno I, Shibagaki Y, Iimuro S, Imai N, Kuwabara M, Hayakawa H, Ohtsu H, Ohashi Y, FEATHER Study Investigators.
    Am J Kidney Dis; 2018 Dec 08; 72(6):798-810. PubMed ID: 30177485
    [Abstract] [Full Text] [Related]

  • 19. Folic acid therapy reduces the risk of mortality associated with heavy proteinuria among hypertensive patients.
    Li Y, Qin X, Luo L, Wang B, Huo Y, Hou FF, Xu X.
    J Hypertens; 2017 Jun 08; 35(6):1302-1309. PubMed ID: 28441699
    [Abstract] [Full Text] [Related]

  • 20. Homocysteine and Stroke Risk: Modifying Effect of Methylenetetrahydrofolate Reductase C677T Polymorphism and Folic Acid Intervention.
    Zhao M, Wang X, He M, Qin X, Tang G, Huo Y, Li J, Fu J, Huang X, Cheng X, Wang B, Hou FF, Sun N, Cai Y.
    Stroke; 2017 May 08; 48(5):1183-1190. PubMed ID: 28360116
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.